Eli Lilly gains as China approves first oral GLP-1 weight-loss pill
Eli Lilly is the first drugmaker to win Chinese approval for a GLP-1 weight-loss pill, lifting shares 2-3%.
What we know
Market news accounts report Lilly became the first drugmaker with a GLP-1 weight-loss pill approved in China, with shares up 2% premarket. Shares later gained 3%.
What people are posting
Posts on X this story draws on. They are individual users' views and have not been verified by Global Eye 24.
@FirstSquawk
“FIRST DRUGMAKER TO HAVE GLP-1 WEIGHT LOSS PILL APPROVED IN CHINA”
View post →By the Global Eye 24 desk, with AI assistance. Updated as the story develops. Spot an error? Write to corrections@globaleye24.com.